6-K

DELAYED FDA APPROVAL OF SUBLOCADE LABEL CHANGES

Company: Indivior Pharmaceuticals, Inc.
Filed: February 12, 2025
Period of Report: February 12, 2025
Accession Number: 0001654954-25-001381

View Document ↗ View on SEC.gov ↗